NCT03478020View on ClinicalTrials.gov

Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

March 29, 2018

Study Completion Date

April 5, 2018

Conditions
Healthy Volunteer
Interventions
DRUG

AQX-1125

Investigational Drug

DRUG

Combined Oral Contraceptive

COC containing 100 ug Levonorgestrel (LNG) and 20 ug Ethinyl Estradiol (EE)

Trial Locations (1)

Unknown

PRA Health Sciences - Early Development Serices, Groningen

Sponsors
All Listed Sponsors
lead

Aquinox Pharmaceuticals (Canada) Inc.

INDUSTRY